Dupont Capital Management Corp bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 240 shares of the medical equipment provider’s stock, valued at approximately $251,000.
Other hedge funds have also made changes to their positions in the company. ETF Managers Group LLC purchased a new position in Intuitive Surgical during the 2nd quarter worth $110,000. Harvest Fund Management Co. Ltd purchased a new position in Intuitive Surgical during the 2nd quarter worth $120,000. Parallel Advisors LLC grew its stake in Intuitive Surgical by 3.9% during the 2nd quarter. Parallel Advisors LLC now owns 159 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 6 shares during the last quarter. Advisors Capital Management LLC purchased a new position in Intuitive Surgical during the 3rd quarter worth $209,000. Finally, Ken Stern & Associates Inc. purchased a new position in Intuitive Surgical during the 2nd quarter worth $210,000. Hedge funds and other institutional investors own 31.30% of the company’s stock.
In related news, CFO Marshall Mohr sold 6,000 shares of Intuitive Surgical stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $372.22, for a total value of $2,233,320.00. Following the completion of the transaction, the chief financial officer now owns 12,316 shares in the company, valued at approximately $4,584,261.52. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Alan J. Levy sold 2,997 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $371.35, for a total value of $1,112,935.95. The disclosure for this sale can be found here. In the last three months, insiders sold 36,076 shares of company stock valued at $15,208,381. Insiders own 2.20% of the company’s stock.
Several research analysts recently weighed in on ISRG shares. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Morgan Stanley restated an “overweight” rating on shares of Intuitive Surgical in a research note on Tuesday, September 5th. Citigroup Inc. restated a “buy” rating and set a $119.78 target price (up from $101.89) on shares of Intuitive Surgical in a research note on Monday, July 24th. Barclays PLC restated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, October 20th. Finally, Vetr downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $112.28 target price on the stock. in a research note on Thursday, July 20th. Six equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $154.72.
Intuitive Surgical, Inc. (ISRG) opened at $392.12 on Tuesday. The stock has a market capitalization of $43,940.00, a PE ratio of 51.50, a PEG ratio of 5.44 and a beta of 0.46. Intuitive Surgical, Inc. has a fifty-two week low of $203.57 and a fifty-two week high of $393.51.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The business had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company’s revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.06 EPS. research analysts anticipate that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This report was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/11/14/dupont-capital-management-corp-takes-251000-position-in-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.